Dr. Lin joins Nuvig to advance NVG-2089 through Phase 2 studies in chronic inflammatory demyelinating polyneuropathy and ...

The hybrid CME/CE event featured expert sessions on neurological disorders, emerging technologies, and evidence-based care, strengthening the knowledge and skills of clinicians across the neurology ...

The S&P 1500 Health Care Index gained 1.9% in September, underperforming the S&P 500, which advanced 3.7%. Read more here.

The thought 'no-one is accountable' for the death of Helen Holland, the 81-year-old hit by the Duchess of Edinburgh's royal ...

VYVGART ® SC is first and only neonatal Fc receptor blocker approved to treat CIDP Authorization is based on global ADHERE study, the largest clinical trial in CIDP to date First novel, targeted ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

About 6 in 10 Americans are currently living with at least one chronic condition. (Nov. 6, 2025) Kansas mayor hit with criminal charges for allegedly voting as noncitizen in several elections 10 ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Icecure Medical ( (ICCM)) has issued an ...

Even if smoking, diet, and blood pressure improve across the population, England faces millions more people living with multiple chronic conditions by 2043, highlighting that healthier ageing, not ...

There are two types of inflammation: acute and chronic. Acute inflammation is the kind that lasts a few hours, days, or weeks, and it’s helpful to healing. It’s your immune system’s response when ...

Detailed price information for Zai Lab Ltd ADR (ZLAB-Q) from The Globe and Mail including charting and trades.